Skip to main content
Clinical Trials/CTRI/2024/06/069435
CTRI/2024/06/069435
Not yet recruiting
Phase 4

A comparative study of lignocaine nebulization with intravenous lignocaine for attenuation of pressor response to laryngoscopy and intubation - NI

Hublikar Hemanth0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Hublikar Hemanth
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Hublikar Hemanth

Eligibility Criteria

Inclusion Criteria

  • All ASA 1 and 2 patients between 18\-65 years posted for elective surgeries under general anesthesia.

Exclusion Criteria

  • 1\) ASA grade 3 and 4\.
  • 2\) Diabetic and Hypertensive patients.
  • 3\) known history of drug allergy.
  • 4\) Pregnant and lactating women.
  • 5\) Chronic respiratory and cardiovascular disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials